Baudax Bio Stock

Baudax Bio P/B

Delisted

P/B (Price-to-Book Ratio) of Baudax Bio (BXRX) as of Aug 8, 2026.

P/B

0.00

Last updated:

P/B (Price-to-Book Ratio) of Baudax Bio is 2026 0.00 . P/B (Price-to-Book Ratio) of Baudax Bio was 2025 -0.19 . It decreases by % higher compared to the previous year.
Access this data via the Eulerpool API

Baudax Bio Stock analysis

What does Baudax Bio do? Baudax Bio Inc is a leading biotechnology company that provides innovative products and solutions to improve human health. The company was founded in 2019 and is headquartered in Malvern, Pennsylvania. It is listed on the NASDAQ Capital Market. Baudax Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Baudax Bio stock

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Baudax Bio since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Baudax Bio with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Baudax Bio

All Key Metrics — Baudax Bio